{"id":"W2307171802","doi":"10.1007/s40273-016-0401-4","title":"Use of Intermediate Endpoints in the Economic Evaluation of New Treatments for Advanced Cancer and Methods Adopted When Suitable Overall Survival Data are Not Available","year":2016,"lang":"en","type":"review","venue":"PharmacoEconomics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Economic evaluation; Medicine; Health economics; Proxy (statistics); Population; Quality-adjusted life year; Quality of life (healthcare); Time horizon; Clinical endpoint; Quality of Life Research; Cost effectiveness; Actuarial science; Clinical trial; Intensive care medicine; Public health; Statistics; Internal medicine; Environmental health; Risk analysis (engineering); Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04750898,0.001915774,0.00655506,0.00765587,0.0004386207,0.005029093,0.002223428,0.002224557,0.004338178],"category_scores_gemma":[0.077831,0.0005822634,0.006255403,0.007994689,0.001346078,0.003087143,0.001929968,0.004259838,0.0004137502],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002737187,"about_ca_system_score_gemma":0.004541714,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002731462,"about_ca_topic_score_gemma":0.004750808,"domain_scores_codex":[0.9733372,0.01905367,0.002995872,0.0009411041,0.003310706,0.0003614115],"domain_scores_gemma":[0.9200268,0.07170153,0.004799446,0.00102121,0.002171828,0.000279305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001539815,0.0002396296,0.004287927,0.1064455,0.009961746,0.0001309803,0.000132266,0.008937374,0.0002685893,0.04645887,0.006369801,0.8152273],"study_design_scores_gemma":[0.001985789,0.002252928,0.03279221,0.3329441,0.04480388,0.001787127,0.0006753395,0.0138702,0.002543615,0.2039752,0.3618304,0.0005391033],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001109259,0.9900379,0.00532608,0.0009329971,0.000230651,0.0001749205,0.0003583664,0.000009787213,0.001820035],"genre_scores_gemma":[0.03797586,0.9402522,0.01794404,0.001082411,0.000531921,0.0009496544,0.0007051077,0.00002622095,0.0005325479],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.04750898,"threshold_uncertainty_score":0.2512546,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.7785772792293135,"score_gpt":0.5996900770819155,"score_spread":0.1788872021473981,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}